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Na,K-ATPase and Related Cation Pumps: 
Structures, Mechanisms, and Diseases
(Organized by David Gadsby, Jack Kaplan, and Jerry Lingrel)
The 59th Symposium of the Society of General 
Physiologists focused on the topic of Na,K-ATPase and 
Related Cation Pumps: Structures, Mechanisms, and 
Diseases. The meeting was also the 11th International 
ATPase Conference, a triennial event; the previous 
conjunction of these two meetings occurred in 1990. 
The Symposium took place at the Marine Biological 
Laboratory in Woods Hole, MA, on September 6–11, 
2005. It was organized by David Gadsby (The Rockefeller 
University), Jack Kaplan (University of Illinois Chicago), 
and Jerry Lingrel (University of Cincinnati). There were 
 250 attendees representing 21 different countries. The 
program featured 35 invited speakers and 165 posters. 
As suggested by the title, the meeting covered a range of 
topics pertaining to the P-type ATPases, including their 
atomic structure, enzymology, regulation, and role in 
physiological and pathological processes. This summary 
includes contributions from the Chairs of the six sympo-
sium sessions and other participants as indicated next 
to the session titles. Numbers in parentheses in the text 
indicate the abstract number published in the Journal of 
General Physiology, Vol. 126, No. 1, July 2005.
Session I. 
Atomic Structure 
(Paul De Weer, University of Pennsylvania)
Findings presented at the fi  rst session reinforce the no-
tion that P-type transport ATPases function according to 
the “alternating access” principle where the transported 
(or countertransported) substrate on its trip across the 
membrane binds at an essentially “stationary” locus 
whose affi  nity and directional accessibility are regulated 
by cyclical structural rearrangements.
In the session on atomic structure, Y. Sugita presented 
recent work from the laboratory of C. Toyoshima 
(University of Tokyo) on attempts to identify candidate 
protonation sites in the transmembrane Ca-binding 
loci, and to elucidate the role of proton countertrans-
port in the operation of the SERCA1a calcium ATPase 
(1). Continuum electrostatic calculations on a previ-
ously solved Ca-bound structure of SERCA1a in the E1 
form had shown that two acid residues in the Ca-bind-
ing region were likely to be protonated and, as con-
fi   rmed by molecular dynamics simulations, to lend 
stability to the Ca binding site through hydrogen bond-
ing. A new high-resolution (2.4 Å) x-ray structure of the 
enzyme crystallized in the E2 form in the absence of 
Ca2+ and presence of the inhibitors thapsigargin and 
dibutylhydroxybenzene was obtained. The structure re-
veals, besides the inhibitors, individual water molecules, 
several phospholipid molecules (one of them wedged 
between helices M2 and M4), and a new conformation 
for the backbone of Glu-309, which is generally ac-
cepted to form part of the cytoplasmic access gate. This 
high-resolution Ca2+-free structure was used to assess 
the protonation status of residues in the now-empty Ca-
binding site. Interatomic distances, electrostatic calcu-
lations, and MD simulations all point to four protonated 
residues, compared with two in the Ca-bound E2 con-
formation. Absent knowledge about the source (cyto-
plasmic or SR luminal) of these protons, the transport 
stoichiometry remains uncertain. The Tokyo group ar-
gues that two to three protons are transported per cycle 
and that all P-type ATPases must effect countertrans-
port of protons and/or other ions.
J. Møller (University of Aarhus) briefl  y summarized 
advances in overexpression of rabbit SERCA1a in 
Saccharomyces cerevisiae followed by biotin-based purifi  ca-
tion, functional reconstitution, crystallization, and x-ray 
analysis, promising tools for future structural work on 
recombinant Ca-ATPase (2). Turning to x-ray structures 
of native SERCA1a crystallized in two conformations 
(Ca2-E1 complexed with AMPPCP or ADP + AlF4
− and 
Ca-free E2 complexed with AlF4
−  + thapsigargin), 
Møller offered a conformational analysis of the cou-
pling between movements of the cytoplasmic N, P, and 
A domains that accompany phosphorylation–dephos-
phorylation steps and those of the transmembrane seg-
ment that result in Ca2+ and H+ transport. Despite 
minimal structural differences, the Aarhus group views 
the Ca2-E1 complex with ADP + AlF4
− (which mimics 
the phosphorylation transition state), rather than the 
complex with AMPPCP, as being most representative of 
the occluded state. Nucleotide binding to Ca2-E1 causes 
large sequential cytoplasmic domain movements that 
result in the A domain pulling the long M2 helix and 
kinking M1 to plug cytoplasmic access to the Ca-bind-
ing sites; phosphorylation (which requires Ca2+ to be 
bound) then locks Ca2+ in place. After phosphoryl 
transfer and ADP release, the enzyme acquires the con-
77formation of the dephosphorylation transition state 
represented by the complex with AlF4
− + thapsigargin, 
which has no luminal access and where a large move-
ment of the A domain, with multiple tugs on the trans-
membrane segment, has destabilized the Ca2+ binding 
while keeping cytoplasmic access plugged by M1-M2; to 
accommodate the demonstrated intervening Ca2+/H+ 
exchange, an intermediate state with luminal access is 
postulated. Phosphoenzyme hydrolysis (which requires 
the binding sites to be protonated) then locks the lumi-
nal door on H+. Subsequent phosphate release removes 
the cytoplasmic plug, allowing H+/Ca2+ exchange and 
reinitiation of the cycle.
S.J.D. Karlish (Weizmann Institute) described the 
characterization, in anticipation of structural work on 
recombinant enzyme, of pig Na,K-ATPase obtained by 
large-scale expression of α and (His-tagged) β subunits 
in the methylotrophic yeast Pichia pastoris (3). The pro-
tein, detergent solubilized and purifi  ed by metal-chelate 
and size-exclusion chromatography, remains inactive 
unless prepared with added phospholipids. Solubilized 
enzyme, native (from kidney) as well as recombinant, 
sediments and chromatographs as an αβ complex. It 
has lower specifi  c activity and higher ouabain sensitiv-
ity than membrane-bound native enzyme, which pre-
sumably refl  ects stabilization of the E1 conformation. 
β-Subunit deglycosylation removes activity but not with 
dioleoyl-phosphatidylserine present. Cholesterol, at 
least in the presence of dioleoylphosphatidylcholine, 
stabilizes the enzyme at higher temperatures.
O. Dmitriev (University of Wisconsin) described the 
solution-NMR structure of the 165-residue N (nucle-
otide binding) domain of the human P1-type copper-
transporting ATPase, mutations of which underlie 
Wilson’s disease, a severe hepato-neurological disorder 
caused by copper accumulation. The N domain of 
P1-type ATPases shows little homology with that of 
P2-type (including bacterial heavy metal) ATPases and 
harbors an extra insert. However, among P1 members, 
the N-domain core is highly conserved, including invar-
iant His-1069, mutation of which to Gln most commonly 
underlies Wilson’s disease. The N domain was found to 
consist of a β sheet fl  anked by two pairs of α helices. 
Identifi  cation of residues involved in ATP binding re-
vealed no residue contacting the γ-phosphate, three 
glycine residues contacting β-phosphate, and His-1069 
contacting both β-phosphate and adenine.
M. Haupt (Technische Universität München) dis-
cussed the solution-NMR structure of the N domain (at 
136 residues the smallest known) of KdpFABC, a K+ -
transporting ATPase from Escherichia coli, which consists 
of four subunits, one of which (KdpA) shows similari-
ties to KcsA-type K+ channel subunits, whereas the cata-
lytic KdpB subunit is homologous to other P-type 
ATPases and shares their structural organization into a 
seven-helix transmembrane segment and cytoplasmic 
A, P, and N domains. The N domain structure was found 
to consist of a β sheet fl  anked by two pairs of α helices. 
Nucleotide binding was found to occur by sandwiching 
of the purine ring by π:π and cation:π interaction be-
tween Phe-377 and Lys-395, respectively. No signifi  cant 
conformational changes accompanied nucleotide 
binding.
Session II. 
Ion Binding Sites and Transport Mechanisms 
(Luis Beaugé, Instituto M. y M. Ferreira)
The contributions in this session dealt with structure–
function relationships in P-ATPases associated with 
binding and translocation of the transported ions. A 
variety of plasma membrane ATPases were featured, 
such as those involved in the coupled transport of Na+ 
and K+, Ca2+ and H+, or H+ and K+, as well as bacterial 
heavy metal transporting enzymes. Most presentations 
included site-specifi   c mutations followed by analy-
sis of transport function parameters or, in one case, 
of ion movement in a pump transformed into an ion 
channel.
The Ca-ATPase now has high-resolution structures as-
sociated with several different states of the enzyme, as 
discussed above. J.P. Andersen and colleagues (University 
of Aarhus) discussed the functional analysis of site-di-
rected mutations with respect to these structures (8). In 
particular, they identifi  ed residues important in E1-E2 
conformational changes, Ca3+ and nucleotide binding, 
and K-dependent dephosphorylation of the E2-P con-
formation. These studies are forging an understanding 
of the nature of the interactions within the protein, and 
with ligands, that drive the transport cycle in these 
pumps.
Although the atomic structure of the Na,K-ATPase 
has not been determined directly, general structural 
features have been inferred using homology modeling 
based on the Ca-ATPase. Various steps in the ion trans-
location pathway were discussed at new levels of detail. 
P.L. Jørgensen (University of Copenhagen) described 
events involved in binding of Na+ from the cytoplasm 
(4). Na+ is thought to promote its own entry into the 
transport pathway by opening the cytoplasmic gate con-
trolling access to cation binding sites. The gate is then 
closed by ATP binding and subsequent phosphoryla-
tion, so occluding the ions. The open state of the gate is 
associated with an increase in the rate of chymotryptic 
cleavage of the α-subunit of the pump at Leu-266, indi-
cating a conformational change that makes this residue 
more accessible.
The binding sites at which Na+ resides after passing 
through the cytoplasmic gate were extensively discussed. 
H.-J. Apell (Universität Konstanz) described the ion-
binding events as sequential, with the occupancy of sites 
triggering changes in protein conformation that allow 
the pump transport reaction to cycle (6). An analysis of 
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that most of the voltage dependence of the pumping 
rate arises from the electrodiffusion of ions through the 
associated pore to and from the binding sites, rather 
than from the conformational changes of the protein 
or the phosphorylation/dephosphorylation reactions 
that underlie the gating process. The overall net charge 
movement by the pump ultimately results from the 
asymmetry in the number of Na+ (3) and K+ (2) ions 
translocated with each cycle. While the structure of the 
Ca-ATPase suggests the position of two of the ion-bind-
ing sites in the Na,K-ATPase, the location of the third 
site for Na+ ions is less clear. J.D. Horisberger and col-
leagues (Université de Lausanne) used mutagenesis to 
search for residues that affect Na+- but not K+-depend-
ent kinetics of the pump (39). They identify a putative 
binding site in a cavity bounded by the transmembrane 
(TM) segments 5, 6, 8, and 9. Similar work presented by 
Taniguchi et al. (40) assigned interactions with Thr-774 
in TM5 as an important component in the binding of 
the third Na+ ion. Horisberger et al. also identifi  ed 
parts of the second and third extracellular loops of the 
α-subunit that are possibly linked to the gate that con-
trols movement of ions between their binding sites and 
the extracellular fl  uid.
The nature of this part of the Na+ translocation path-
way was further investigated by P. Artigas and colleagues 
(The Rockefeller University). The marine toxin paly-
toxin opens gates in the Na,K pump, turning it into 
ouabain-inhibitable ion channel. Mutations and MTS 
modifi  cations at position 131 in TM2 and other residues 
at the extracellular ends of TMs 1, 2, and 6 alter the sin-
gle-channel conductance in a charge-dependent man-
ner, suggesting these aspects of the protein form the 
outer mouth of the channel. Modifi  cations at Thr806, 
at the top of TM6, decrease conductance irrespective of 
charge, indicating steric effects in a narrowed part of 
the pore.
Ion-binding sites have also been identifi  ed in heavy- 
metal transporting (type P1B) ATPases, as described by 
J. Argüello (Worcester Polytechnic Institute). As in the 
other ATPases, these binding sites are complex, involv-
ing coordination of the metals by amino acids in TMs 6, 
7, and 8 (corresponding to TMs 4, 5, and 6 of the 
PII-ATPases). Site-directed mutagenesis studies revealed 
that these binding sites conferred the heavy-metal spe-
cifi  cities that characterize this class of pumps.
Session III. 
Cation Pump Subunit Interaction 
(Kazuya Taniguchi, Hokkaido University)
Cation pump subunit interactions presented in the 
conference fell into two categories, one related to inter-
actions between protomers, αβ or αβγ in monovalent 
cation pumps or conformational variants in SR-Ca-
ATPase, and the other to interactions between the gly-
cosylated β-chain and catalytic α-chain. Although the 
speakers mainly concentrated on the latter category, 
interactions between protomers, presented mainly in 
posters, may be important for a full understanding of 
pump function.
The oligomericity of Na/K-ATPase was proposed 
more than 30 years ago (Repke and Schon, 1973; Stein 
et al., 1973). Recent experimental evidence to show oli-
gomericity has been reviewed (Askari, 1987, 2000; 
Schoner et al., 1994; Taniguchi et al., 2001). Studies of 
ATP binding to Na,K-ATPase and H,K-ATPase showed 
the simultaneous presence of EP:EATP in the mem-
brane-bound Na/K- (9, 93) and H/K-ATPase (9, 90). 
One mole of Pi is liberated from each 0.5 mol of EP and 
0.5 mol of EATP simultaneously during the H-ATPase 
reaction, providing strong functional evidence for the 
oligomericity of the enzyme. Single molecule detection 
techniques for FITC-treated H/K-ATPase (76) and 
high-performance liquid chromatography of Na/
K-ATPase (83) showed that the soluble tetrameric struc-
ture is fully active in both Na,K-ATPase and H/K-ATPase. 
Hayashi et al. (83) showed that the stoichiometry of 
ouabain binding to each protomer, diprotomer, and 
tetraprotomer is close to 1:1:0.75, respectively, and that 
the fraction of tetraprotomer in C12E8-solubilized 
Na,K-ATPase increased by >50% in the presence of 
phosphatydylserine at acidic pH. Kutchai and Thomas 
(86) showed the presence of diprotomer, tetraprotomer, 
and much larger oligomers in membrane Na,K-ATPase 
after treatment with subsolubilizing levels of SDS using 
time resolved phosphorescence anisotropy. Gable et al. 
(77) suggested that the binding of SDS to the enzyme 
increased the clustering of protomers through α–α con-
tacts at discrete domains. Nakamura et al. (44) proposed 
the existence of two conformational variants in SR-Ca-
ATPase molecules that bind two calcium ions, noncoop-
eratively and positive-cooperatively, respectively, in the 
absence of high concentrations of ATP. Glycerol 
changed the calcium-sensing characteristics of SR-Ca-
ATPase, implying the participation of water molecules 
in calcium binding and/or subunit interactions. In sum-
mary, these results suggest that Na,K-ATPase and related 
pumps may operate not as independent monomers, as 
implied by the Post-Albers scheme, but as higher-order 
structures containing interacting catalytic units.
In the symposium session, E. Bamberg (Max-Planck-
Institut für Biophysik) proposed that the α–β subunit 
interaction has a direct role in catalytic activity assessed 
using the techniques of cysteine-scanning mutagenesis 
and voltage-clamp fl  uorimetry (61), permitting the ki-
netic effects of [Na+]i-dependent steps on electrogenic 
partial reactions of the Na pump to be examined. The 
results underlined the role of the Na,K-ATPase β-subu-
nit as a modulating cofactor in the enzymatic properties 
of the holoenzyme (80). Bamberg also presented meas-
urements of fluorescence resonance energy transfer 
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between the α and β subunits showing movement of 
defi  ned residues during the Na,K-ATPase reaction (79). 
J. Kaplan (University of Illinois Chicago) proposed the 
β-subunit–dependent polarization of the Na,K-ATPase 
(87), and the extent of glycosylation of the β2-subunit 
appeared to play a signifi  cant role in Na pump plasma 
membrane delivery in renal cells (78). O. Vagin et al. 
(University of California Los Angeles) had previously 
demonstrated that a reduction in β-subunit glycosyla-
tion in the case of H,K-ATPase reduced apical localiza-
tion, increased ER retention, and increased degradation 
of H,K-ATPase. Further studies (94) showed that six of 
the seven N-glycosylation sites in the H,K-ATPase β-sub-
unit are essential for its apical sorting in LLC-PK1 cells. 
Data obtained from site-directed mutations introduced 
into Na,K-ATPase β chains to increase the number of 
N-glycosylation sites show that the N-glycans linked to 
the β-subunit isoform of P2-type ATPases contain apical 
sorting information.
Rajasekaran et al. (11, 89, 155) provided evidence that 
Na,K-ATPase, the protein serine/threonine phosphatase 
PP2A, the phospholipid-binding protein annexin II, and 
occludin form a novel apical junctional complex in-
volved in the regulation of tight-junction permeability in 
epithelial cells. They also showed that the β-subunit is 
involved in the suppression of carcinoma cell motility by 
a mechanism involving an interaction between the two 
subunits of Na/K-ATPase and PI-3-kinase signaling path-
way. The decreased cell motility of β-expressing cells is 
due to an increased attachment of these cells to the sub-
stratum, where the activation of the focal adhesion ki-
nase by Src is involved.
Further studies to clarify the role of subunit interac-
tions during active transport of cations as well as in the 
regulation of cation pumps are eagerly awaited.
Session IV. 
Inherited Dysfunction of Cation Pumps 
(Carolyn Slayman, Yale University)
Genetic studies of membrane transport have increased 
in recent years with the introduction of powerful new 
methods to map, clone, and manipulate mammalian 
genes. On the one hand, large-scale genome sequenc-
ing and haplotype mapping have made it relatively 
straightforward to pinpoint genes that correspond to 
known, transport-related phenotypes. In parallel, it is 
now easier than ever before to introduce desired mu-
tations into the mouse genome for in vivo functional 
analysis of individual transporters. Session IV provided 
fi  ve excellent examples of studies in this broad area.
In the fi  rst talk, S. Lutsenko (Oregon Health and 
Sciences University) described the function and regula-
tion of two human copper-transporting ATPases known 
as the Menkes disease protein (MNKP) and Wilson’s 
disease protein (WNDP) (Barnes et al., 2005) (15). 
These ATPases, which are 60% identical in amino acid 
sequence, were originally discovered by cloning the 
genes for inherited neurodegenerative disorders. They 
have since been shown to pump copper from the cyto-
plasm into the secretory pathway, contributing to the 
biosynthesis of secreted copper-dependent enzymes 
and helping to maintain the intracellular copper con-
centration. Lutsenko and her colleagues have used 
high-resolution fl  uorescent imaging to explore the cel-
lular and subcellular distribution of MNKP and WNDP 
in the mouse cerebellum, where both are expressed. 
WNDP is localized in Purkinje neurons, where it pro-
vides copper for the biosynthesis of secreted proteins 
such as ceruloplasmin, while MNKP switches its location 
from Purkinje neurons in early development to closely 
associated Bergmann glial cells in the adult animal. 
Interestingly, inactivating the WNDP gene leads to a 
shift in ceruloplasmin expression from Purkinje neu-
rons to Bergmann glia, where MNKP can now provide 
the required copper. Thus, there is clearly crosstalk be-
tween the two cell types in the regulation of copper 
distribution.
The second talk was part of a long-term study by inves-
tigators at the University of Cincinnati, who are using 
gene-knockout techniques to dissect the physiological 
roles of the four α-subunit isoforms of mammalian 
Na,K-ATPase (14). The general approach has been to 
construct mice that lack either one copy (heterozygous 
animals) or both copies (homozygous null animals) of 
each of the isoform genes. Although homozygous 
knockouts for the α1, α2, and α3 subunits have proved 
to be lethal before or at birth, all three heterozygotes 
are viable and fertile. A. Moseley has now examined the 
behavior of these animals using a variety of standard 
methods to assess anxiety (“zero maze” test) and spatial 
learning and memory (Morris water maze). While α1+/− 
mice appeared normal, α2+/− mice had reduced loco-
motor ability and heightened anxiety, and both α2+/− 
and  α3+/− mice showed evidence of impairment in 
learning and memory. Taken together, the results point 
to a role of Na,K-ATPase α isoforms in the modulation 
of behavior.
The remainder of the session explored the way in 
which human mutations have begun to shed light on 
the role of Na,K-ATPase in brain function. K. Sweadner 
(Massachusetts General Hospital) began by reviewing 
recent work in this fi  eld (12). Six different mutations of 
the Na,K-ATPase α3-subunit in eight unrelated families 
have now been linked to a dominant disorder known as 
rapid onset dystonia Parkinsonism (RDP), in which 
metabolic stress leads to involuntary muscle contrac-
tions (de Carvalho Aguiar et al., 2004) (12). In parallel, 
15 mutations of the Na,K-ATPase α2-subunit in 16 fami-
lies have been linked to a different disorder known as 
familial hemiplegic migraine type 2 (FHM2). As pointed 
out by Sweadner, it is probably signifi  cant that the α3-
subunit is expressed only in neurons, where it makes a Palmer 81
small hyperpolarizing contribution to membrane po-
tential, while the α2-subunit is expressed preferentially 
in astrocytes, where an impairment of K+ clearance 
might be expected to lead to migraines and epilepsies. 
Sweadner and her coworkers have mapped the muta-
tions associated with RDP and FHM2 onto structural 
models of the α-subunit and found that most of the af-
fected amino acid residues are predicted to be buried 
within the protein at important intramolecular contact 
points. Indeed, when this idea was tested by transfecting 
several of the mutant forms into oocytes, reduced ex-
pression was seen, consistent with defects in protein 
folding and/or stability. B. Vilsen (University of Aarhus) 
next presented the results of detailed studies on two 
mutations of the Na,K-ATPase α3-subunit leading to 
RDP: F785L, located near the end of membrane-span-
ning segment 5, and T618M, located within the P do-
main. Neither mutation completely destroys ATPase 
function. Rather, both lead to complex sets of kinetic 
alterations, with a reduction in the affi  nity of the E1 
form of the ATPase for Na+ but no change in the affi  n-
ity of the E2P form for K+. Similarly, R. Blostein (McGill 
University) described three mutations of the Na,K-
ATPase α2-subunit that result in familial hemiplegic mi-
graine type 2 (Segall et al., 2004): T345A, R689Q, and 
M731T (13). All three mutant ATPases display measura-
ble, although abnormal, activity. In one case (T345A), 
K+ affi  nity is decreased, while the remaining two mu-
tants display a reduction in catalytic turnover. As work 
progresses on both RDP and FHM2, it seems likely that 
useful insights will emerge into the structure–function 
relationships of the α2 and α3 isoforms and the role of 
both isoforms in the brain.
Session VA. 
Regulation of Cation Pumps: FXYD proteins 
(Haim Gary, Weizmann Institute)
FXYD proteins are a group of seven short transmem-
brane proteins named after the invariant extracellular 
motif F·X·Y·D. The various members of this family have 
been shown to interact specifi  cally with the Na,K-ATPase 
and alter its kinetic properties. Since each of them has 
a characteristic tissue distribution, it is assumed that 
FXYD proteins are tissue-specifi  c modulators or auxilia-
ry subunits of the Na, K-ATPase, which adapt its kinetic 
properties to the physiological needs of a particular tis-
sue, cell type, or physiological state, without affecting 
it elsewhere (for a recent review see Garty and Karlish, 
2005). The best studied family members are phospho-
lemman (FXYD1), the major phosphoprotein in heart 
and muscle; the γ-subunit of Na,K-ATPase (FXYD2), 
a kidney-specifi  c auxiliary subunit of the pump; CHIF 
(FXYD4), an aldosterone-induced protein expressed in 
kidney and colon; and FXYD10, a phospholemman-like 
protein from shark rectal gland. The four speakers in 
this session addressed various aspects of the structural 
and functional interactions between FXYD proteins and 
the α-subunit of the Na,K-ATPase. The major conclu-
sions, supported by complementary data from different 
laboratories are as follows. (a) The transmembrane do-
main of FXYD proteins plays a key role in their effects 
on the apparent affi  nity of the pump for cytoplasmic 
Na+ and extracellular K+. (b) This segment is located 
in a groove formed between the second, fourth, and 
ninth transmembrane domains (TM2, TM4, and TM9) 
of the α-subunit of Na,K-ATPase. (c) The FXYD trans-
membrane domain is also critical for the high affi  nity 
interactions with α, but the residues involved are differ-
ent from those mediating the functional effects.
K. Geering (Université de Lausanne) reported a muta-
tion analysis of TM9, identifying residues involved in the 
interactions with FXYD proteins (16). One conclusion is 
that different amino acids mediate the effi  cient associa-
tion with FXYD proteins and the functional effects of 
these FXYD proteins on the K+ affi  nity of Na,K-ATPase. 
This conclusion was confi  rmed by tryptophan-scanning 
mutagenesis analysis of the transmembrane domain of 
FXYD7. The amino acids required for effi  cient associa-
tion with α appear to be clustered in a region that con-
tains two well conserved glycines. In the second part of 
her presentation Geering reported the characterization 
of FXYD3, a poorly studied member of the family. This 
FXYD protein was found to have two unique properties. 
First, unlike FXYD1, FXYD4, and FXYD5, the putative 
signal peptide of FXYD3 is not cleaved and therefore it 
may have two, rather than one, transmembrane do-
mains. Second, FXYD3 appears to be the only member 
of the family that interacts with the H,K-ATPase, in addi-
tion to the Na, K-ATPase.
Structural aspects of FXYD proteins were addressed 
further by F. Marassi (Burnham Institute). Her group 
expressed FXYD1, FXYD3, and FXYD4 in E. coli and 
studied the structure of the purifi  ed proteins in deter-
gent micelles and lipid bilayers by NMR spectroscopy. 
The transmembrane domains of the three proteins 
were found to be “classical” α helices with a periodicity 
of 3.6 residues. The transmembrane helix is fl  anked by 
two additional short helical regions in the extracellular 
and intracellular domains and a fourth helical segment 
is found near the COOH terminus. Interestingly, the 
boundaries between the helical regions and the con-
necting segments coincide with the positions of intron–
exon junctions in the corresponding genes. This may 
account for the puzzling observation that in spite of the 
small size of FXYD proteins (<100 amino acids), each 
of them is coded by at least six exons, and the conserved 
35–amino acid segment is made up of three separate 
exons. The above data suggest that the FXYD proteins 
may have been assembled from small discrete structural 
modules through exon shuffl  ing.
The third presentation by F. Cornelius (University of 
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phosphorylation-induced conformational change of 
the cytoplasmic segment of this protein (17). The struc-
tural interactions between shark Na,K-ATPase and the 
cytoplasmic domain of FXYD10 were investigated using 
chemical cross-linking, which has placed the COOH 
terminus of FXYD10 in the vicinity of Cys-254 in the A 
domain of α. Such interactions within the A domain 
could explain the inhibitory effects of FXYD10 and the 
effects of its phosphorylation. Experiments with NH2-
terminal truncation of α and addition of exogenous 
FXYD10 indicate an interaction between these moieties 
in shark enzyme, but not in pig kidney enzyme.
In the fi  nal talk, H. Garty (Weizmann Institute) dis-
cussed structural and functional features of the trans-
membrane domains of a number of FXYD proteins 
(18). Chemical cross-linking has located Cys-49 in the 
transmembrane segment of FXYD4 at a distance of 3–6 
Å from Cys-140 in the TM2 domain of α. Similar inter-
actions have been demonstrated for the corresponding 
FXYD1 and FXYD2 residues (Phe-48 and Phe-36, re-
spectively), suggesting that the general disposition of 
the three FXYD proteins with respect to TM2 is similar. 
The fact that FXYD2 and FXYD4 have opposite effects 
on the apparent affi  nity of the Na,K-ATPase for cell Na+ 
has been used to analyze the structure–function rela-
tionships of these proteins. Examining the functional 
effects of FXYD2/FXYD4 chimeras as well as mutants in 
which individual amino acids were exchanged between 
the two proteins has underscored the key role of several 
transmembrane residues in determining the apparent 
affi  nity of the pump for cell Na+.
Together, these four presentations provided valuable 
new insights into the structure and structure–function 
relationships of FXYD proteins and established the role 
of this family in the physiological regulation of the Na, 
K ATPase.
Session VB. 
Regulation of Cation Pumps: Phospholamban, Sarcolipin and 
Receptor-mediated Regulation 
(Lawrence G. Palmer, Cornell University)
The fi  fth session of the symposium focused on the regu-
lation of Na,K-ATPase and Ca-ATPase, particularly by 
phosphorylation-dependent events. There are at least 
two such pathways. One involves phosphorylation-de-
pendent movement of pump proteins to and from the 
plasma membrane. The other entails the modulation 
by phosphorylation of the interactions of pumps with 
accessory membrane proteins.
A. Bertorello (Karolinska Institute) described the 
traffi  cking of Na,K-ATPase, particularly in response to 
signals from G protein–coupled receptors. These events 
are clearly important in regulating pump activity in epi-
thelial cells (21). In renal cells, activity is increased by 
angiotensin II and decreased by dopamine and parathy-
roid hormone. This regulation correlates well with 
changes in transepithelial Na+ reabsorption by the re-
nal proximal tubule in response to these hormones, 
and refl  ects insertion of pumps into and retrieval from 
the plasma membrane, respectively. Lung epithelial 
cells also regulate the number of pumps on their sur-
face, although the signal transduction pathways are dif-
ferent. Dopamine, for example, which decreases pump 
activity in the kidney, actually increases it in the lung. C. 
Pedemonte (University of Houston) discussed the in-
volvement of phosphorylation in these events, particu-
larly the roles of two phosphorylation sites in the 
α1-subunit of Na,K-ATPase, Ser-18, and Ser-11 (147). 
When epithelial cells were transfected with pumps car-
rying the S11A mutation, both stimulation of activity by 
angiotensin II and phorbol ester and inhibition by 
dopamine were abolished. Ser-18 was also essential for 
regulation of pump activity in opossum kidney cells. 
Phosphorylation of these sites appears to be required 
for regulated traffi  cking of the protein rather than for 
activity per se.
The sarcoplasmic/endoplasmic reticulum Ca-ATPase 
(SERCA) and its interaction with the accessory protein 
phospholamban (PLB) provide an example of the sec-
ond type of regulation. D. Thomas (University of 
Minnesota) used several biochemical approaches to 
study this phenomenon (19). FRET analysis indicated 
that the two membrane proteins bind to each other 
with high affi  nity. PLB inhibits pump activity, and this 
inhibition, but not binding itself, is relieved either by 
high Ca2+ concentrations or by phosphorylation of PLB 
at Ser-19. NMR and EPR techniques were used to deter-
mine the structure of PLB in lipid micelles. The cyto-
plasmic domain of the protein can adopt several 
conformations with increasing degrees of disorder and 
extension, with phosphorylation favoring the ordered 
state. Thomas proposed that the most extended and 
disordered form of PLB is responsible for inhibition of 
the pump, acting by preventing ATP-induced changes 
in the P-domain of SERCA. Phosphorylation of PLB 
would then relieve inhibition through stabilization of 
the ordered state of the cytoplasmic tail.
A similar scheme may account for modulation of 
Na,K-ATPase in cardiac myocytes by β-adrenergic sig-
nals. D. Bers (Loyola University Chicago) and colleagues 
showed that the β-adrenergic agonist isoproterenol 
stimulated pump activity by decreasing the apparent Km 
of the pump for intracellular Na+ (123). This regula-
tion involves the FXYD-protein phospholemman (PLM) 
as it is absent in PLM-knockout mice. FRET analysis in-
dicated a direct interaction between Na,K-ATPase and 
PLM in the membrane of HEK293 cells (122); this in-
teraction was reduced by activation of either PKA or 
PKC. This suggests that hormones such as noradrena-
line may increase pump activity by phosphorylating 
PLM and reversing the increased Km for Na+ that results 
from PLM binding.Palmer 83
Session VC. 
Regulation of Cation Pumps: Speciﬁ  c P-type ATPase Inhibitors
(Robert Farley, University of Southern California)
Symposium session V continued the theme of regulation 
of cation pumps with two presentations dealing with spe-
cifi  c P-type ATPase inhibitors. Perhaps the best known 
P-type ATPase inhibitors are the cardiac glycosides such 
as ouabain and digitalis, which inhibit Na,K-ATPase. 
The inhibition of the sodium pump by these molecules 
was originally discovered by Hans Schatzmann who pub-
lished this result in 1953. Schatzmann was looking to ob-
tain evidence in erythrocytes to support the suggestion 
by W. Wilbrandt that mineralocorticoids might stimu-
late Na+ transport in the kidney tubule because they 
chelate the ion and function as a mobile Na+ carrier, or 
as the Na-binding site in a pump protein. Frustrated by 
the failure to observe the expected stimulation of Na+ 
transport, Schatzmann decided to try another steroid, 
k-strophanthoside, which produced a clear inhibition 
of the pump. An account of this discovery is provid-
ed in Schatzmann’s recollection published in 1995 
(Schatzmann, 1995). It quickly became apparent that 
rodent Na,K-ATPase is far less sensitive to inhibition by 
cardiac glycosides than other species. The explanation 
for this observation was provided in 1988 by Price and 
Lingrel (1988), who showed that two charged amino ac-
ids in the Na,K-ATPase α-subunit at the border between 
the membrane and the extracellular loop connecting 
TM 1 and 2 were responsible for the relative resistance 
of the rodent pump. These amino acids are not charged 
in sensitive species. The difference in these amino ac-
ids between sensitive and resistant species is not suffi  -
cient to explain the specifi  city of cardiac glycosides for 
Na,K-ATPase, however, because the gastric H,K-ATPase, 
which is not inhibited by these molecules, also has the 
uncharged amino acids at these positions. Many reports 
that describe effects of site-directed mutations on car-
diac glycoside affi  nity or inhibition of the sodium pump 
have been published from different labs in an effort to 
defi  ne the essential amino acids in the binding site for 
these molecules. The conclusions drawn from these re-
ports are limited, however, because they describe loss-of-
function mutations. In his presentation in this session, 
J.J. de Pont (Radbaud University) described the use of 
chimeric Na,K-/H,K-ATPase polypeptides and point 
mutations to confer high-affi  nity ouabain binding to the 
gastric H,K-ATPase (20). In the end, gastric H,K-ATPase 
containing only seven amino acids from Na,K-ATPase 
in the extracellular loops connecting TM 3 and 4, and 
TM 5 and 6, bound ouabain with an affi  nity comparable 
to that of native Na,K-ATPase. Similar high-affi  nity oua-
bain binding was conferred to the ouabain-insensitive 
nongastric H,K-ATPase using the same approach. Of 
course, additional amino acids are probably involved in 
the recognition of the cardiac glycosides by the protein, 
but they are the same in the two ATPases. A homology 
model was described for Na,K-ATPase, based on the E2P 
crystal structure of Ca-ATPase, in which the amino acids 
identifi  ed by de Pont and his collaborators, and several 
other amino acids identifi  ed earlier in loss-of-function 
mutants, are important for cardiac glycoside binding.
The second group of specifi  c P-type ATPase inhibi-
tors discussed in this session were the inhibitors of the 
gastric H,K-ATPase. Two classes of molecules have been 
found to be important and useful inhibitors of this en-
zyme. The fi  rst class is the pyridylmethylsulfi  nyl benzi-
madazoles such as omeprazole. These molecules were 
shown to inhibit gastric acid secretion in the late 1970s 
and the H,K-ATPase in the early 1980s. They are weak 
bases that accumulate in acid space of the secretory ca-
naliculus where they are acid activated to form cationic 
thiophilic intermediates. There they react with one or 
more cysteine sulfhydryls at the luminal surface of the 
acid pump to form disulfi  de bonds with the protein. 
These covalent inhibitors of the H,K-ATPase have had 
widespread commercial success, with omeprazole sold 
over the counter as Prilosec, and lansoprazole (Prevacid) 
being the no. 3 prescription drug sold in the USA in 
2004 with over $4 billion in sales. The second class of 
inhibitors is the substituted imidazo [1,2a]pyridines, 
which are K+-competitive inhibitors of the H,K-ATPase. 
The best known example of these molecules is 
SCH28080, and although several derivatives of this drug 
have been developed, they are not yet on the market. 
These drugs were serendipitously discovered and shown 
to inhibit gastric H,K-ATPase in the early 1980s with 
submicromolar IC50 values. G. Sachs (University of 
California Los Angeles) delivered a comprehensive 
presentation about the two classes of H,K-ATPase inhib-
itors and their interaction with the pump. A homology 
model for the H,K-ATPase was developed based on the 
crystal structure of Ca-ATPase, and the effects of many 
point mutations in the H,K-ATPase on omeprazole or 
SCH28080 affi  nity were explained using this model. A 
mechanism of hydronium ion transport by the ATPase 
was proposed, and a molecular dynamics simulation for 
the path of K+ binding to the pump showed the impor-
tance of several amino acids in this process. This simula-
tion also demonstrated the importance of these amino 
acids in the competitive inhibition of K+ binding by 
SCH28080.
Session VD. 
Regulation of Cation Pumps: Signaling via Na,K-ATPase 
(Amir Askari, Medical University of Ohio)
Though this session was listed under the heading 
“Regulation of Cation Pumps,” the topics covered repre-
sent the other side of the regulation coin, i.e., regulation 
by Na,K-ATPase of the functions of other cellular pro-
teins. This is a relatively new area of research. Of course, 
it has been known for a long time that ion pumping by 
Na,K-ATPase is essential to the life of most mammalian 84 Meeting Summary
cells, and that some specialized cell functions (e.g., car-
diac contractility) are regulated by changes in intrac-
ellular ion concentrations that result from alterations 
of the pumping function of this enzyme. What is new 
about Na,K-ATPase and signaling is the recent realiza-
tion (Xie and Askari, 2002) that many of the regulatory 
effects of Na,K-ATPase on cellular functions are not the 
consequence of changes in its ion pumping function, 
but rather due to interaction of pump proteins with the 
neighboring membrane proteins, the ligand-induced 
changes in these protein–protein interactions, and the 
resulting alterations in the network of signaling cas-
cades that are known to be linked to these pump neigh-
bors. The invited speakers of this symposium covered 
selected topics in this growing area of research.
The introductory remarks by the chair (A. Askari, 
Medical University of Ohio) dealt with the existence 
and mechanism of amplifi  cation within the signaling 
pathways that are linked to Na,K-ATPase, and are acti-
vated in response to ouabain and related cardiac glyco-
sides that are also considered to be the endogenous 
physiological ligands of this enzyme/receptor (Schoner 
and Scheiner-Bobis, 2005). In a number of recent stud-
ies on different types of intact cells, it has been noted 
that ouabain-induced signaling and its varied down-
stream effects (e.g., stimulation or inhibition growth) 
are obtained at such low ouabain concentrations that 
little or no inhibition of the pumping function of Na,K-
ATPase is measurable. Such fi  ndings have often raised 
questions, either by the investigators doing the work or 
by critics, as to whether these low-dose effects may be 
due to ouabain binding to receptors other than Na,K-
ATPase. The speaker suggested signal amplifi  cation, a 
well recognized phenomenon in receptor biology, as a 
more reasonable explanation (164). He presented data 
showing that in human breast cancer cells, where low 
and nonlethal concentrations of ouabain inhibit prolif-
eration through transactivation of Src/EGFR, sustained 
activation of ERK1/2, and the resulting induction of 
p21Cip1 there is indeed such amplifi  cation, and that oc-
cupation of <10% of the receptors (Na,K-ATPase) by 
the signal (ouabain) is suffi  cient to yield >90% response 
(growth arrest) (Kometiani et al., 2005). Regarding the 
most likely mechanism of this gain in sensitivity, it was 
suggested, by analogy with the extensively studied am-
plifi  cation in bacterial chemotaxis, that clusters/teams 
of the oligomeric Na,K-ATPase and its signaling part-
ners within the restricted space of caveolae may be re-
sponsible for this signal amplifi  cation (164).
In the presentation by Z. Xie (Medical University of 
Ohio), emphasis was on the interaction of Na,K-ATPase 
with Src. He reviewed his published data on ouabain-in-
duced signaling in caveolae of the renal epithelial cells, 
indicating that an early event in the signaling cascade is 
the activation of Src. New evidence was then presented 
to show that this is indeed due to the direct interaction 
of Src with the α-subunit of Na,K-ATPase. Using purifi  ed 
kidney Na,K-ATPase, recombinant Src, and GST- and 
His-tagged fusion products of the various Src and α-sub-
unit domains, the results of in vitro binding assays 
showed the following. (a) Src interacts with α-subunit at 
two sites, one involving the binding of Src’s SH2 domain 
to the cytoplasmic domain of α-subunit that connects 
transmembrane helices 2 and 3, and the other, the bind-
ing of Src’s kinase domain to the cytoplasmic domain 
connecting transmembrane helices 4 and 5 of α-subunit. 
(b) The latter interaction causes Src inhibition, and oua-
bain disrupts this interaction, disinhibiting the bound 
Src. FRET and BRET analyses in intact cells transfected 
with tagged constructs of Src and α-subunit were then 
presented that supported the conclusions of the binding 
assays. This is the fi  rst defi  nitive identifi  cation of an im-
mediate signaling partner of Na,K-ATPase, allowing fur-
ther studies on the molecular details of Src interaction 
with Na,K-ATPase. Xie also presented FRET data indi-
cating that inactive mutants of α-subunit (D369N and 
D369E) also interact with Src, providing further support 
for the independence of the signaling function of Na,K-
ATPase from its catalytic and pumping functions.
Once it is realized that Na,K-ATPase may function as 
a signal transducer due to interaction with neighboring 
signaling proteins, it is evident that there will be signifi  -
cant diversity in the nature of the connected pathways 
and the downstream consequences in different cell 
types. The presentation by G. Scheiner-Bobis (Justus-
Leibig-Universität) exemplifi   ed such diversity (163). 
This laboratory had already shown that in endothelial 
cells of human umbilical artery, low ouabain concentra-
tions that certainly do not inhibit the pump signifi  cantly, 
and may indeed induce activation of ERK1/2, promote 
transcription of the endothelin-1 gene and stimulate 
cell proliferation. Continuing this work, Scheiner-Bobis 
reported new data showing that in these endothelial 
cells, the same low ouabain concentrations activate Akt 
(protein kinase B), a prominent member of the “cell 
survival” squad of protein kinases, and that this is pre-
ceded by the activation of PI3-kinase and followed by 
the activation of eNOS and increased generation of ni-
tric oxide. Evidence was also presented to suggest that 
the above activated cascades may be linked to ouabain-
induced transactivation of the insulin receptor; adding 
this receptor tyrosine kinase to the list of candidates as 
direct interacting neighbors of Na,K-ATPase.
The last speaker of the session, R.G. Contreras (Center 
for Research and Advanced Studies, Mexico) focused 
on the regulation of cell–cell adhesion and cell–sub-
strate attachment by Na,K-ATPase (91, 158). This re-
search team had already reported on the nature of the 
signaling pathways that link Na,K-ATPase to cell attach-
ment. They showed that ouabain and other known in-
hibitors of the enzyme alter intracellular ionic content 
and detachment-related signals, but that there is no Palmer 85
causal association between the signaling events and 
pump inhibition. Reviewing these fi  ndings and present-
ing new data, Contreras concluded that the order in 
which the signaling cascade proceeds to reversible cell 
detachment is as follows: (1) ouabain binding to Na,K-
ATPase, (2) Src activation, (3) ERK1/2 activation, (4) 
inhibition/down-regulation of RhoA, and (5) release of 
occludin, β-catenin, and FAK from tight junctions, ad-
herens junctions, and focal adhesions, respectively. In 
addition to providing insight into the complex mecha-
nisms of cell attachment and their relation to Na,K-
ATPase, these results are of further signifi  cance; thus, 
when considered along with the fi  ndings of other labo-
ratories on the signal transducing effects of Na,K-ATPase 
in renal epithelial cells (Wang et al., 2004), the inescap-
able conclusion is that even in studies of the same cell 
type, each laboratory must be looking, by choice or ne-
cessity, at only a limited segment of a signaling network 
that is enormously complicated. Perhaps it only seems 
to be so at this early phase of the fi  eld’s development.
Session VI. 
Physiological Roles of Cation Pumps 
(Mordecai Blaustein, University of Maryland)
The fi  nal session of the conference was devoted to the 
physiological roles of Na,K-ATPase and Ca-ATPases, 
with emphasis on knowledge gained from null or point 
mutations, or altered physiological conditions. M.P. 
Blaustein (University of Maryland) began the session 
by emphasizing the functional signifi  cance of the Na+ 
pump α-subunit isoforms. His laboratory’s studies us-
ing NH2-terminal 90–120 amino acid segments revealed 
that the sorting signal for the α2 isoform, but not α1, 
is a 10–20 amino acid sequence close to the NH2 ter-
minus. This sequence targets α2 to plasma membrane 
(PM) microdomains that overlie “junctional” sarco-/en-
doplasmic reticulum (S/ER) in astrocytes and arterial 
smooth muscle cells (ASMCs). These cells normally ex-
press α1 and α2 Na+ pumps in  4:1 ratio. Full-length α1 
and α2 isoforms with a protein Ca2+ sensor (GCaMP2) 
attached to the COOH termini were transfected into 
these cells. The expressed α2 fusion protein, but not 
the α1 construct, detected the Ca2+ entry through store-
operated channels (SOCs) that are associated with S/
ER Ca2+ store refi  lling. Thus, α1 and α2 are expressed 
in different, nonoverlapping PM domains; only α2 is 
confi  ned to the PM microdomains at PM-S/ER junc-
tions. What, then, is the difference in the function of 
these 90% identical proteins?
This question was addressed by comparing arterial 
function in wild-type (WT) mice and mice with a null 
mutation in one α1 or one α2 gene (α1+/−and α2+/−; 
lines generated in J.B. Lingrel’s lab). Myogenic tone is 
the spontaneous constriction of intact arteries when in-
traluminal pressure is raised above 10–20 mm Hg. The 
greater the tone, the greater the resistance to blood 
fl  ow and the higher the blood pressure in intact ani-
mals. Low dose (1–100 nM) ouabain, which inhibits 
only the α2 Na+ pumps in rodents, elevated cytoplasmic 
Ca2+ and augmented myogenic tone in small (120–140 
μm diameter) mesenteric arteries. Isolated mesenteric 
arteries from α1+/− mice had normal myogenic tone. In 
contrast, arteries from α2+/− mice, like those from WT 
mice treated with low dose ouabain, had signifi  cantly 
more myogenic tone at intraluminal pressures between 
20 and 100 mm Hg. The increased vascular tone (in 
vitro) was refl  ected by a signifi  cantly higher blood pres-
sure in the α2+/− mice than in the α1+/− or WT mice. 
Thus, α2 Na+ pumps control myogenic tone and long-
term blood pressure; reduced α2 activity increases myo-
genic tone and blood pressure.
J.B. Lingrel (University of Cincinnati) continued 
with this theme of the role of Na+ pump α-subunit iso-
forms in the pathogenesis of hypertension (22). His 
aim is to elucidate the role of the cardiotonic steroid 
binding site on the α-subunit isoforms. He and his col-
leagues have studied two mouse hypertension models: 
the hypertension induced by chronic administration 
of low-dose ouabain and that induced by the adminis-
tration of ACTH, which is known to stimulate the syn-
thesis and secretion of endogenous ouabain by adrenal 
glomerulosa cells. The Lingrel group generated mice 
with a targeted mutation in the α2-subunit ouabain-
binding site that converts it from a high ouabain affi  n-
ity to a low affi  nity site (i.e., ouabain resistant). In 
contrast to the effect in WT mice, blood pressure did 
not rise in the mice with this α2 mutation when oua-
bain was administered chronically. ACTH administra-
tion also failed to elevate blood pressure in mice with 
this α2 mutation. In addition, the ACTH-induced ele-
vation of blood pressure in WT mice was antagonized 
by Digibind, an antibody preparation that is used clini-
cally to treat digitalis intoxication; Digibind binds car-
diotonic steroids including digoxin and ouabain. 
These seminal observations demonstrate, convinc-
ingly, that there is a circulating ligand (a ouabain-like 
compound) for the cardiotonic steroid binding site, 
and that it plays a role in the pathogenesis of some 
forms of hypertension. The data also may resolve a 
long-standing puzzle about the “missing hormone” in 
ACTH-induced hypertension.
Taken together, the observations from the Lingrel 
and Blaustein labs suggest that reduced α2 Na+ pump 
activity plays a key role in some forms of hypertension 
in rodents, in which the α1 isoform has an unusually 
low affi  nity for the drug. In humans, however, α1 as 
well as α2 have a high affi  nity for ouabain. Therefore, 
to examine the role of α1 Na+ pumps, Lingrel and col-
leagues generated mice with mutated α1 (high oua-
bain affi  nity) and α2 (low ouabain affi  nity). ACTH 
very rapidly (within 24 h) induced a severe, Digibind-
sensitive hypertension in these mice. Thus, it appears 86 Meeting Summary
that inhibition of either α1 or α2 can cause hyperten-
sion. But this appears to contradict the evidence (de-
scribed above) that α1+/− mice have normal blood 
pressure, even though expression of the predominant 
α1 isoform is reduced by  50%. A possible explana-
tion is that there may be compensation for prolonged 
(e.g., congenital) reduction of α1 activity (or expres-
sion), whereas reduced α2 activity (or expression) may 
not be compensated. The resolution to this dilemma 
has important implications for understanding the 
pathogenesis of at least some forms of human (essen-
tial) hypertension.
The central role of renal epithelial (α1) Na+ pumps 
in salt (NaCl) and water reabsorption is well docu-
mented; indeed excessive salt reabsorption/retention 
is widely recognized to trigger hypertension. Less well 
recognized is the evidence that α1 Na+ pumps in the 
basolateral membrane of the pulmonary alveolar epi-
thelial cells (AEC) play a critical role in fl  uid reabsorp-
tion from the alveoli. Hypoxia, which may have a 
variety of causes, including the ascent to high altitude, 
and lung pathologies, including pulmonary fi  brosis 
and chronic obstructive pulmonary disease, reduces 
the clearance of alveolar fl  uid by AEC. The accumula-
tion of fl  uid in the alveoli (pulmonary edema) is due 
to a decreased number of Na+ pumps in the AEC 
plasma membrane. J.I. Sznajder (Northwestern 
University) described the mechanism(s) responsible 
for the hypoxia-induced retrieval of Na+ pumps from 
the plasma membrane. Within 6 to 24 h after acute hy-
poxia (8% O2), there is as much as a 50% decrease in 
the Na+ pumps on the surface. The total Na,K-ATPase 
activity in the AEC is not reduced, however. Instead, 
the Na+ pumps are retrieved from the surface by endo-
cytosis and are retained within endosomal vesicles; 
these pumps are available for recycling to the surface 
upon reoxygenation.
A hypoxia-inducible factor, HIF-1α, appears to be the 
master controller for this recycling. Hypoxia, via ubiq-
uination of HIF-1α, stimulates mitochondria to produce 
reactive oxygen species (ROS). ROS promote the re-
trieval of Na+ pumps into endosomes by activating pro-
tein kinase C-ξ (PKC-ξ)–mediated phosphorylation of 
the Na+ pump α1-subunit on Ser-18. Antioxidants, a 
PKC-ξ antagonist (bisindolylmaleimide I, Bis), and mu-
tation of Ser-18 to Ala all prevented the hypoxia-induced 
retrieval of the α1 Na+ pumps.
G. Shull (University of Cincinnati) focused on some 
pathophysiologies of Ca2+ transport; he discussed the 
tumorigenic effects of haploinsuffi  ciency of two differ-
ent Ca-ATPases, SERCA2 and SPCA1 (23). SERCA2 is 
the S/ER Ca2+ pump found in the heart, slow twitch 
skeletal muscle, smooth muscle, and nonmuscle cells 
including adult skin epidermis. In humans, missense 
mutations of SERCA2 have been found in Darier dis-
ease, which is manifested by keratotic lesions of the 
skin and nails. Haploinsuffi  ciency of SERCA2 predis-
poses mice to squamous cell tumors, and represents a 
novel mode of cancer susceptibility. Shull found that 
89% of SERCA2+/− mice developed squamous cell car-
cinomas and papillomas (there were 107 tumors in 49 
mice), whereas only 1 out of 100 WT mice had a tu-
mor. The tumors were heavily keratinized, and were 
associated with increased expression of keratins 6 and 
17 as well as increased p53 and H-ras in the forestom-
ach tumors. These effects were apparently not the re-
sult of SERCA2 insuffi  ciency due to loss of one allele 
because the remaining allele was up-regulated and 
SERCA2 expression was as robust in the WT animals. 
Perhaps it is the factors that promote up-regulation of 
the WT allele in the heterozygotes that induce the 
tumorigenesis.
Hailey-Hailey disease, another dermatosis character-
ized by keratin overexpression, is associated with mis-
sense mutations in SPCA1. This is the secretory pathway 
Ca2+ pump that is found in most cell types and is espe-
cially abundant in keratinocytes and in the kidney. Mice 
with haploinsuffi  ciency of SPCA1 (SPCA1+/−) also de-
velop squamous cell carcinomas and papillomas that 
overexpress keratin; tumors were observed in 6 of 26 
SPCA1+/− mice, but in none of the 23 controls. These 
tumors are, however, later in onset and tend to be 
located in different places than those induced in 
SERCA2+/− mice.
Both SERCA and SPCA affect protein processing 
and traffi  cking. Shull raised the possibility that the in-
crease in cytoplasmic Ca2+ concentration that occurs 
with the haploinsuffi  ciency of either of these pumps 
may, by altering protein processing, exert a permissive 
effect on tumorigenesis. This may provide novel in-
sight into an important pathway that regulates cell 
proliferation.
In sum, these four reports elucidate the central role that 
certain widely distributed ATP-driven ion pumps play in 
some very common pathophysiological processes.
The Na/K pump represents a cornerstone of gen-
eral physiology, creating the ion concentration differ-
ences essential for cell excitability, cell volume control, 
and transepithelial ion and water transport. How the 
protein transduces the chemical energy of ATP into 
that stored in ion gradients remains a critical unsolved 
problem.  However, this symposium showed that an 
understanding of this process at a molecular level may 
be close at hand. Perhaps the most dramatic progress 
in recent years is the elucidation of the atomic struc-
ture of the closely related Ca-ATPase at different stages 
of the pump cycle; similar structures of the Na,K-
ATPase have been inferred by homology and actual 
crystal structures of the Na pump should come soon. 
This information interacts synergistically with increas-
ingly detailed physiological and biochemical measure-
ments of pump function. At the same time, new and Palmer 87
sophisticated genetic and cell biological approaches 
are revealing the roles of the pump in regulating cel-
lular processes. The symposium showed that focusing 
on a single protein family through the lenses of differ-
ent disciplines can reveal much about the workings of 
transporters, cells, and organs.
Lawrence G. Palmer
President 
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